Lenient Pharmaceuticals Private Limited

Lenient Pharmaceuticals Private Limited - trading in New Delhi, Delhi, India. FY 2026 financials & compliance.
CIN U51101DL2015PTC274986 Incorporated 05 January 2015 ROC Delhi HQ New Delhi, Delhi, India
Active Private Limited Company trading
Revenue · FY 2019
₹26.12 Lakh
▲ 6% YoY
Net profit · FY 2019
₹7,488
Net margin 0.3%
EBITDA · FY 2019
₹7,488
EBITDA margin 0.3%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
11 yrs
Est. 2015
Directors on board
3
As per MCA filings
Active GSTINs
1
GST registered

About Lenient Pharmaceuticals Private Limited

Data last updated:

Lenient Pharmaceuticals Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the wholesale distribution segment of the trading and commerce sector. It was incorporated on 05 January 2015 and has been in existence for over 11 years.

The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U51101DL2015PTC274986. Its GSTIN is 07AACCL8005H1ZO (Delhi).

The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Aakash Srivastava and Ankita Srivastava.

Its last annual general meeting (AGM) was held on 30 December 2020, and its latest financial statements are for the year ended 31 March 2020. The registered office is at Office No. – 210 F – 17 2nd Floor Harsha Complex Laxmi Nagar Subhash Chawk, New Delhi, Delhi, India – 110092.

As per the financials filed for FY 2019, the company reported a revenue of ₹26.12 Lakh, a growth of 6% compared to the previous year. For the same year it recorded a net profit of ₹7,488 (net margin 0.3%) and EBITDA of ₹7,488 (EBITDA margin 0.3%). Revenue has grown at a compounded annual rate (CAGR) of 56% over three years.

The current compliance status is marked as compliant by the Registrar of Companies.

Company details

CIN U51101DL2015PTC274986
Registration Number 274986
Incorporation Date 05 January 2015
ROC Delhi
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant

Contact details

Lenient Pharmaceuticals Private Limited's registered office is in New Delhi, Delhi. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    Office No. – 210 F – 17 2nd Floor Harsha Complex Laxmi Nagar Subhash Chawk, New Delhi, Delhi, India – 110092
  • Industry
    Trading, Other Wholesale, Wholesale

To see the full contact details of Lenient Pharmaceuticals Private Limited, buy the company report.

Comprehensive company report
Lenient Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Lenient Pharmaceuticals is support service to organizations. In detail, this covers other support services to organizations.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
NSupport service to OrganizationsN7Other support services to organizations

To see the full business activity and turnover split of Lenient Pharmaceuticals Private Limited, buy the company report.

Financials of Lenient Pharmaceuticals Private Limited

FY 2020 filings available

Lenient Pharmaceuticals Private Limited reported revenue of ₹26.12 Lakh (up 6% YoY) for FY 2019.

Revenue · FY 2019
₹26.12 Lakh ▲ 6%
Net profit · FY 2019
₹7,488 margin 0.3%
EBITDA · FY 2019
₹7,488 margin 0.3%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 6%
3 years · compounded
▲ 56%
EBITDA CAGR growth
1 year
▲ 114%
3 years · compounded
▲ 136%

Revenue has grown at a compounded annual rate (CAGR) of 56% over three years, including 6% growth in the latest year. EBITDA rose 114% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2018-19FY 2017-18FY 2016-17FY 2015-16FY 2014-15
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹7,488
Profit Before Tax
Tax Expense
Net Profit (PAT)₹7,488
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2018-19FY 2017-18FY 2016-17FY 2015-16FY 2014-15
Profitability
EBITDA Margin0.3%
Net Profit Margin0.3%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Lenient Pharmaceuticals Private Limited, buy the company report.

Board of directors of Lenient Pharmaceuticals Private Limited

Lenient Pharmaceuticals has 3 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Aakash SrivastavaDirector16 Sep 20206 Years 2 MonthsCurrent
Ankita SrivastavaDirector05 Jan 201511 Years 10 MonthsCurrent
Inderjeet Singh RawatDirector16 Sep 20206 Years 2 MonthsCurrent

Auditor

Lenient Pharmaceuticals Private Limited is audited by SONIKA AGGARWAL AND COMPANY for the financial year 2017.

Auditor firmFinancial yearFirm registration number
SONIKA AGGARWAL AND COMPANYFY 2017510834

Shareholding

The shareholding of Lenient Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2017FY 2016
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Lenient Pharmaceuticals Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Lenient Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Lenient Pharmaceuticals has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
07AACCL8005H1ZODelhiActive01 Jul 2017

To see the full GST registrations and return filing status of Lenient Pharmaceuticals Private Limited, buy the company report.

Recent activity

Lenient Pharmaceuticals Private Limited has 8 board changes on record since 2015: 3 appointments and 5 cessations. The latest: Aakash Srivastava was appointed as Director on 16 Sep 2020.

AGM
Lenient Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Dec 2020 as per latest MCA records.
Appointed
Aakash Srivastava was appointed as Director.
Ceased
Ashish Kumar ceased to be Director.
Appointed
Inderjeet Singh Rawat was appointed as Director.
Ceased
Rahul Yadav ceased to be Additional Director.
Filing
Lenient Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2020 with Roc Delhi I.
Ceased
Aakash Srivastava ceased to be Director.
Ceased
Rajeev Tyagi ceased to be Director.
Ceased
Shobhit Srivastava ceased to be Director.
Appointed
Ankita Srivastava was appointed as Director.
Incorporation
05 Jan 2015
Lenient Pharmaceuticals Private Limited was registered on 05 Jan 2015 with Roc Delhi I & aged 11 years 10 months as per MCA records.

Frequently asked questions

Lenient Pharmaceuticals is an active private limited company based in New Delhi, Delhi, India. The company works in other wholesale, within the trading industry. It was incorporated on 05 January 2015 (11+ years old) and is registered under CIN U51101DL2015PTC274986.

Lenient Pharmaceuticals has 3 current directors:

The latest financial statements of Lenient Pharmaceuticals on record with the MCA are for the year ended 31 March 2020. Its last annual general meeting was held on 30 December 2020. Year-wise statements from 2015 are in the company report.

The GSTIN of Lenient Pharmaceuticals is 07AACCL8005H1ZO, registered in Delhi.

The CIN (Corporate Identification Number) of Lenient Pharmaceuticals is U51101DL2015PTC274986. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Lenient Pharmaceuticals was incorporated on 05 January 2015, making it 11+ years old. It is registered with the Registrar of Companies, Delhi.

Aakash Srivastava was appointed as Director on 16 Sep 2020. Ashish Kumar ceased to be Director on 16 Sep 2020. Inderjeet Singh Rawat was appointed as Director on 16 Sep 2020. Lenient Pharmaceuticals has 8 board changes on record in total.

The registered office of Lenient Pharmaceuticals is at Office No. – 210 F – 17 2nd Floor Harsha Complex Laxmi Nagar Subhash Chawk, New Delhi, Delhi, India – 110092.

Lenient Pharmaceuticals operates in the trading industry, in the other wholesale segment.

The compliance status of Lenient Pharmaceuticals is compliant as of 14 July 2026. The company is actively filing with the Registrar of Companies.